CIK 0001453687
- Non-accelerated filer
- Smaller reporting company
Cartesian Therapeutics, Inc.
Sign in to watch- Ticker
- RNAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-348-8698
- Business address
- 7495 NEW HORIZON WAY, FREDERICK, MD, 21703
- Former names
- SELECTA BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-01-25 | Nashat Amir Director | Purchase | +7,711 | $1.50 | $12K | 18,329 |
| 2019-01-25 | Nashat Amir Director | Purchase | +11,258 | $1.50 | $17K | 26,760 |
| 2019-01-25 | Nashat Amir Director | Purchase | +1,125,756 | $1.50 | $1.7M | 2,676,234 |
| 2019-01-07 | Kishimoto Takashi Kei Chief Scientific Officer | Exercise or conversion | +36,114 | $2.77 | $100K | 36,114 |
| 2019-01-07 | Kishimoto Takashi Kei Chief Scientific Officer | Exercise or conversion · Employee Stock Option (right to buy) | −36,114 | $2.77 | $100K | 43,629 |
| 2019-01-07 | Johnston Lloyd P. COO and SVP, R&D | Grant or award · Employee Stock Option (right to buy) | +100,000 | $2.60 | $260K | 100,000 |
| 2019-01-07 | Smolinski Stephen Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +100,000 | $2.60 | $260K | 100,000 |
| 2019-01-07 | Kishimoto Takashi Kei Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +100,000 | $2.60 | $260K | 100,000 |
| 2018-12-02 | Farokhzad Omid Director | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2018-12-01 | Brunn Carsten President and CEO | Grant or award · Stock Option (Right to Buy) | +1,000,000 | 1,000,000 | ||
| 2018-12-01 | Brunn Carsten President and CEO | Grant or award · Restricted Stock Units | +175,000 | 175,000 | ||
| 2018-06-15 | Johnston Lloyd P. COO and SVP, R&D | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2018-06-15 | Kishimoto Takashi Kei Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2018-06-15 | Abraham David GC, CCO & Corporate Secretary | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2018-06-15 | Smolinski Stephen Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2018-06-15 | Leaman John Harold CFO, Treas. & Hd Corp Strategy | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2018-06-15 | Farokhzad Omid Director | Grant or award · Stock Option (Right to Buy) | +15,404 | 15,404 | ||
| 2018-06-15 | BARABE TIMOTHY C Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2018-06-15 | HUTT PETER BARTON Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2018-06-15 | Nashat Amir Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 |
Page 31 of 32 · 631 trades